Longevity science is at a critical moment in time. In the wake of the COVID-19 pandemic investors, regulators and the medical community have woken up to the promise of ageing science and its potential to completely change how we prevent and treat disease. Advanced analytical tools are driving huge strides in our understanding of ageing biology and potential targets, and a number of high-profile fund raises are driving investor interest in the space.
Meanwhile, regenerative medicine goes from strength to strength, with the success of autologous stem cell treatments and renewed interest from the aesthetics industry. Gene therapies continue to show promise and inch closer to adoption. This is an incredibly exciting time to be a part of the growing longevity community.
The Longevity Leaders World Congress brings the world’s most prominent longevity scientists together, presenting the new research, responsible drug development and commercialisation. We’d love you to join us!
.jpg)
